Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization
暂无分享,去创建一个
C. Lau | H. Tse | Jun-zhu Chen | Jian-hua Zhu | J. Ge | Qing-yong Zhang | Liang-hui Zhang
[1] W. Burns,et al. Connective Tissue Growth Factor and Cardiac Fibrosis after Myocardial Infarction , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[2] Wei Zhao,et al. Cytokine Production by Skin-Derived Mast Cells: Endogenous Proteases Are Responsible for Degradation of Cytokines 1 , 2005, The Journal of Immunology.
[3] M. Hauer-Jensen,et al. Cardiac function in hearts isolated from a rat model deficient in mast cells. , 2005, American journal of physiology. Heart and circulatory physiology.
[4] Wei Zhao,et al. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. , 2005, Journal of immunology.
[5] H. Thorlacius,et al. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids , 2004, Inflammation Research.
[6] N. Khaper,et al. Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.
[7] S. Yoshida,et al. Induction of IL-8, MCP-1, and bFGF by TNF-α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[8] S. Zahler,et al. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. , 2003, Cardiovascular research.
[9] C. D. dos Remedios,et al. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. , 2003, European heart journal.
[10] M. Ward,et al. Tranilast Prevents Activation of Transforming Growth Factor-&bgr; System, Leukocyte Accumulation, and Neointimal Growth in Porcine Coronary Arteries After Stenting , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[11] A. Maes,et al. Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. , 2002, European heart journal.
[12] G. Heusch,et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-&agr;, and Sphingosine , 2002, Circulation research.
[13] A. Yeung,et al. Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection , 2001, Circulation.
[14] R. Erbel,et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. , 2000, American journal of physiology. Heart and circulatory physiology.
[15] G Baumgarten,et al. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. , 2000, American journal of physiology. Heart and circulatory physiology.
[16] E. Topol,et al. Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.
[17] S. Galli. Mast cells and basophils , 2000, Current opinion in hematology.
[18] KohOno,et al. Mast Cells Cause Apoptosis of Cardiomyocytes and Proliferation of Other Intramyocardial Cells In Vitro , 1999 .
[19] J. Folts. Deleterious hemodynamic effects of thrombotic/embolic materials on the distal myocardial vasculature. , 1999, Cardiovascular research.
[20] M. Entman,et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. , 1999, Circulation.
[21] M. Lindsey,et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. , 1998, Circulation.
[22] E. Arbustini,et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. , 1998, Circulation.
[23] B. Reichart,et al. Epicardial intimal thickening in transplant coronary artery disease and resistance vessel response to adenosine: a combined intravascular ultrasound and Doppler study. , 1997, Circulation.
[24] P. Anversa,et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[25] E. Arbustini,et al. Immunological characterization and functional importance of human heart mast cells. , 1995, Immunopharmacology.
[26] L. Vaca,et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.
[27] H. M. Payne,et al. Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.
[28] K. Rakušan,et al. Mast cells in the rat heart during normal growth and in cardiac hypertrophy. , 1990, Circulation research.
[29] T. Nishigaki. Mast cell degranulation and its inhibition by an anti-allergic agent tranilast , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.
[30] M. Davies,et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. , 1986, Circulation.
[31] E. Genton,et al. The Relevance of Platelet and Fibrin Thromboembolism of the Coronary Microcirculation, with Special Reference to Sudden Cardiac Death , 1980, Circulation.
[32] M. Spatz. Bismarck brown as a selective stain for mast cells. , 1960, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.
[33] R. Erbel,et al. Coronary microembolization: the role of TNF-alpha in contractile dysfunction. , 2002, Journal of molecular and cellular cardiology.
[34] R. Erbel,et al. Coronary microembolization. , 2000, Journal of the American College of Cardiology.
[35] F. Granata,et al. Chapter 29 – Human Heart Mast Cells: Immunological Characterization In Situ and In Vitro , 2000 .
[36] E. Arbustini,et al. Laura Cardiomyopathy Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic , 1998 .